Results 261 to 270 of about 197,386 (292)

Exosome-niosome hybrid oxygen carrier for protection against acetaminophen-induced acute liver injury.

open access: yesBiomater Sci
Bushra A   +6 more
europepmc   +1 more source

Dynamic chemical labelling accurately quantifies microRNA-122 and reveals the presence of isomiRs that compromise PCR-based analysis in drug-induced liver injury

open access: yes, 2019
Dear, James; id_orcid 0000-0002-8630-8625   +6 more
openaire   +1 more source

Chemical Probes for drug-induced Liver Injury Imaging

Future Medicinal Chemistry, 2020
Drug-induced liver injury (DILI) has been a long-standing concern of modern medicine, and the single most frequent reason for drug nonapprovals and postapproval restrictions or withdrawals. Chemical probes for early diagnosis of DILI has triggered a tremendous interest in the field of molecular imaging.
Tao Jiang, Pengfei Rong
exaly   +3 more sources

The chemical, genetic and immunological basis of idiosyncratic drug–induced liver injury [PDF]

open access: yesHuman and Experimental Toxicology, 2015
Idiosyncratic drug reactions can be extremely severe and are not accounted for by the regular pharmacology of a drug. Thus, the mechanism of idiosyncratic drug–induced liver injury (iDILI), a phenomenon that occurs with many drugs including β-lactams, anti-tuberculosis drugs and non-steroidal anti-inflammatories, has been difficult to determine and ...
Dean John Naisbitt
exaly   +3 more sources

MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury [PDF]

open access: yesJournal of Clinical Medicine, 2015
Drug-induced liver injury (DILI) is major problem for both the drug industry and for clinicians. There are two basic categories of DILI: intrinsic and idiosyncratic. The former is the chief cause of acute liver failure in several developed countries, while the latter is the most common reason for post-marketing drug withdrawal and a major reason for ...
Mitchell McGill, Hartmut Jaeschke
exaly   +3 more sources

Ferroptosis: action and mechanism of chemical/drug-induced liver injury

Drug and Chemical Toxicology, 2023
Drug-induced liver injury (DILI) is characterized by hepatocyte injury, cholestasis injury, and mixed injury. The liver transplantation is required for serious clinical outcomes such as acute liver failure. Current studies have found that many mechanisms were involved in DILI, such as mitochondrial oxidative stress, apoptosis, necroptosis, autophagy ...
Li Zeng   +8 more
openaire   +2 more sources

Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries

Toxicology and Applied Pharmacology, 2012
Although estrogen receptor (ER)α agonists, such as estradiol and ethinylestradiol (EE2), cause cholestasis in mice, they also reduce the degree of liver injury caused by hepatotoxicants as well as ischemia-reperfusion. The functional mechanisms of ERα have yet to be elucidated in drug-induced or chemical-induced liver injury.
Tatsuki Fukami, Tsuyoshi Yokoi
exaly   +3 more sources

Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data

Toxicology and Applied Pharmacology, 2022
Drug-induced liver injury (DILI) and cardiotoxicity (DICT) are major adverse effects triggered by many clinically important drugs. To provide an alternative to in vivo toxicity testing, the U.S. Tox21 consortium has screened a collection of ∼10K compounds, including drugs in clinical use, against >70 cell-based assays in a quantitative high-throughput ...
Lin, Ye   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy